Guardian Pharmacy Services, Stock Price Prediction
| GRDN Stock | 24.94 0.02 0.08% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Guardian Pharmacy hype-based prediction, you can estimate the value of Guardian Pharmacy Services, from the perspective of Guardian Pharmacy response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Guardian Pharmacy to buy its stock at a price that has no basis in reality. In that case, they are not buying Guardian because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Guardian Pharmacy after-hype prediction price | USD 25.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Guardian |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardian Pharmacy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardian Pharmacy After-Hype Price Prediction Density Analysis
As far as predicting the price of Guardian Pharmacy at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Guardian Pharmacy or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Guardian Pharmacy, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Guardian Pharmacy Estimiated After-Hype Price Volatility
In the context of predicting Guardian Pharmacy's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Guardian Pharmacy's historical news coverage. Guardian Pharmacy's after-hype downside and upside margins for the prediction period are 21.42 and 28.80, respectively. We have considered Guardian Pharmacy's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Guardian Pharmacy is not too volatile at this time. Analysis and calculation of next after-hype price of Guardian Pharmacy is based on 3 months time horizon.
Guardian Pharmacy Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Guardian Pharmacy is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Guardian Pharmacy backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Guardian Pharmacy, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.02 | 3.69 | 0.17 | 0.14 | 5 Events / Month | 2 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
24.94 | 25.11 | 0.68 |
|
Guardian Pharmacy Hype Timeline
Guardian Pharmacy is currently traded for 24.94. The entity has historical hype elasticity of 0.17, and average elasticity to hype of competition of -0.14. Guardian is forecasted to increase in value after the next headline, with the price projected to jump to 25.11 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.68%, whereas the daily expected return is currently at 1.02%. The volatility of related hype on Guardian Pharmacy is about 2612.39%, with the expected price after the next announcement by competition of 24.80. The company reported the previous year's revenue of 1.05 B. Net Income was 23.9 M with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out Guardian Pharmacy Basic Forecasting Models to cross-verify your projections.Guardian Pharmacy Related Hype Analysis
Having access to credible news sources related to Guardian Pharmacy's direct competition is more important than ever and may enhance your ability to predict Guardian Pharmacy's future price movements. Getting to know how Guardian Pharmacy's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Guardian Pharmacy may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GRDN | Guardian Pharmacy Services, | 0.17 | 5 per month | 3.17 | 0.24 | 6.15 | (5.35) | 21.67 | |
| RHE-PA | Regional Health Properties | 0.00 | 0 per month | 5.08 | 0.14 | 30.43 | (13.89) | 107.06 | |
| NVOS | Novo Integrated Sciences | 0.00 | 0 per month | 0.00 | (0.15) | 11.54 | (17.57) | 90.12 | |
| IMG | CIMG Inc | (0.01) | 5 per month | 10.34 | 0.09 | 13.46 | (23.23) | 582.01 | |
| GIFT | RDE, Inc | 0.04 | 10 per month | 0.00 | (0.15) | 9.29 | (13.08) | 28.43 | |
| HTLM | HomesToLife | (1.19) | 2 per month | 7.01 | 0.03 | 7.69 | (10.07) | 37.34 | |
| JCTC | Jewett Cameron Trading | (0.14) | 3 per month | 0.00 | (0.11) | 2.87 | (4.22) | 9.61 | |
| QRTEP | Qurate Retail | 0.00 | 0 per month | 1.91 | (0.01) | 3.90 | (3.23) | 9.82 |
Guardian Pharmacy Additional Predictive Modules
Most predictive techniques to examine Guardian price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Guardian using various technical indicators. When you analyze Guardian charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Guardian Pharmacy Predictive Indicators
The successful prediction of Guardian Pharmacy stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Guardian Pharmacy Services,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Guardian Pharmacy based on analysis of Guardian Pharmacy hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Guardian Pharmacy's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Guardian Pharmacy's related companies.
Story Coverage note for Guardian Pharmacy
The number of cover stories for Guardian Pharmacy depends on current market conditions and Guardian Pharmacy's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Guardian Pharmacy is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Guardian Pharmacy's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Guardian Pharmacy Short Properties
Guardian Pharmacy's future price predictability will typically decrease when Guardian Pharmacy's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Guardian Pharmacy Services, often depends not only on the future outlook of the potential Guardian Pharmacy's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardian Pharmacy's indicators that are reflective of the short sentiment are summarized in the table below.
| Dividends Paid | 38.4 M |
Check out Guardian Pharmacy Basic Forecasting Models to cross-verify your projections. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.